--- title: Planning for Cell & Gene Therapy Commercialization    description: Planning for Cell & Gene Therapy Commercialization   - Bringing cell & gene therapies to market is no easy feat. We are bringing you industry advice from biopharma leaders on how to tackle commercialization best. image: https://www.lsxleaders.com/hubfs/Planning%20for%20Cell%20%26%20Gene%20Therapy%20Commercialization.png --- [![LSX The Network for Life Science Executive Leaders](https://www.lsxleaders.com/hubfs/lsx%20f.jpg "LSX The Network for Life Science Executive Leaders")](https://www.lsxleaders.com/) --- ![_Planning for Cell & Gene Therapy Commercialization (5)](https://www.lsxleaders.com/hs-fs/hubfs/_Planning%20for%20Cell%20%26%20Gene%20Therapy%20Commercialization%20%20%20%20%20%20(5).png?width=847&height=476&name=_Planning%20for%20Cell%20%26%20Gene%20Therapy%20Commercialization%20%20%20%20%20%20(5).png)   # Planning for Cell & Gene Therapy Commercialization    --- A panel discussion with: - ** ****Matt Booth**, SVP Global Therapy Lead, **ApotheCom, An Inizio Company** -  **Ben Beckley**, President, **Evoke Mind + Matter, An Inizio Company**  -  **Dean McAlister**, EVP,** I****nizio Biotech**** ** -  **Greg Christianson,** Principal, **Nuvera, An Inizio Company** -  **Rita Johnson-Green****e**, COO, **All****iance for Regenerative Medicine (ARM)**  Bringing cell & gene therapies to market is no easy feat. The many technicalities involved in running trials, scaling manufacturing capabilities, market access and launch drives up end-to-end costs, meaning patients are often faced with a complex, long and expensive road to treatment. With the aim to bring CGT’s to as many patients as possible, panellists discuss the early-commercial planning factors facing CGT companies today and tried-and-tested solutions. --- Watch now ---       **In partnership with** --- ![Inizio Biotech Logo](https://www.lsxleaders.com/hs-fs/hubfs/Inizio%20Biotech%20Logo.png?width=150&height=75&name=Inizio%20Biotech%20Logo.png) Inizio unlocks the value of your healthcare innovation by connecting best-in-class strategic, analytic, and creative capabilities. By bridging our scientific knowledge, market intelligence, actionable data, cutting-edge technology, and creative execution, Inizio is by your side to help you confidently navigate the complex asset lifecycle, rising to any challenges together.  [https://inizio.health/](https://inizio.health/)    ##### ABOUT [LSX](https://www.lsxleaders.com/) is the Life Science eXecutive partnering community.   We connect biotech, medtech & healthtech executives with access to the capital, intelligence, innovation, and partners they need to grow their businesses. ##### EVENTS [Female Founders](https://www.lsxleaders.com/female-founders) [Inv€$tival Showcase](https://www.lsxleaders.com/investival-showcase) [European Lifestars Awards](https://www.lsxleaders.com/lifestars-awards) [LSX Nordic Congress](https://www.lsxleaders.com/lsx-nordic-congress) [LSX USA Congress](https://www.lsxleaders.com/lsx-usa-congress) [LSX World Congress](https://www.lsxleaders.com/lsx-world-congress) [RNA Leaders Europe](https://www.lsxleaders.com/rna-leaders-world-congress) [RNA Leaders USA](https://www.lsxleaders.com/rna-leaders-usa-congress) [The $yndicate](https://www.lsxleaders.com/syndicate-investment) [Workforce Wellbeing](https://www.lsxleaders.com/workforce-wellbeing-congress) ##### CONNECT [Message us](https://www.lsxleaders.com/contact-us) [Home](https://www.lsxleaders.com/) [LSX](https://www.lsxleaders.com/) Informa Connect, 240 Blackfriars Road, London SE1 8BF, United Kingdom   [![Twitter](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-twitter.png?width=23&height=24&name=Biotech-twitter.png "Twitter")](https://twitter.com/LSXLeaders)    [![Facebook](https://www.lsxleaders.com/hs-fs/hubfs/fbook%20option%203.png?width=24&height=24&name=fbook%20option%203.png "Facebook")](https://facebook.com/LSXLeaders)    [![Youtube](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-youtube.png?width=23&height=24&name=Biotech-youtube.png "Youtube")](https://www.youtube.com/channel/UCBjBilvMaUhkgWLjQ95NIQg)    [![Linkedin](https://cdn2.hubspot.net/hub/459002/hubfs/biotech_and_Money/Biotech-Linkedin.png?width=23&height=24&name=Biotech-Linkedin.png "Linkedin")](https://www.linkedin.com/company/lsx-leaders/)   [![Net Zero Website Logo](https://tree-nation.com/images/tracking/label-co2-website-black-en.png) ](https://tree-nation.com/profile/impact/lsx-ltd#co2) [contact](https://www.lsxleaders.com/contact-us) | [privacy policy](https://www.lsxleaders.com/privacy-policy) | [good conduct policy](https://www.lsxleaders.com/good-conduct-policy) | [anti-slavery policy](https://www.lsxleaders.com/anti-slavery-policy) | [anti-money laundering & financial crime policy](https://www.lsxleaders.com/anti-money-laundering-financial-crime-policy) | [diversity & inclusion policy](https://www.lsxleaders.com/diversity-inclusion-policy) | [terms & conditions](https://www.lsxleaders.com/terms-conditions) © 2022 all rights reserved by LSX Ltd